Get the Stockscreener App
4.49
0.00%
0.00
After Hours:
4.49
Sensus Healthcare Inc stock is traded at $4.49, with a volume of 9,927.
It is up +0.00% in the last 24 hours and up +15.42% over the past month.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
See More
Previous Close:
$4.49
Open:
$4.53
24h Volume:
9,927
Relative Volume:
0.12
Market Cap:
$73.91M
Revenue:
$27.48M
Net Income/Loss:
$-7.72M
P/E Ratio:
-9.4986
EPS:
-0.4727
Net Cash Flow:
$332.00K
1W Performance:
+1.58%
1M Performance:
+15.42%
6M Performance:
+30.14%
1Y Performance:
-3.44%
1-Day Range:
$4.37
$4.53
1-Week Range:
$4.25
$4.55
52-Week Range:
$3.03
$5.92
Sensus Healthcare Inc Stock (SRTS) Company Profile
Name
Sensus Healthcare Inc
Sector
Industry
Phone
561-922-5808
Address
851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL
Compare SRTS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRTS
Sensus Healthcare Inc
|
4.49 | 73.91M | 27.48M | -7.72M | 332.00K | -0.4727 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Initiated | Alliance Global Partners | Buy |
| Jan-31-25 | Initiated | Lake Street | Buy |
| Nov-15-24 | Reiterated | Maxim Group | Buy |
| Feb-26-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Dec-16-20 | Downgrade | Northland Capital | Outperform → Market Perform |
| Aug-10-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Feb-14-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Nov-07-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jan-29-19 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-26-18 | Initiated | B. Riley FBR | Buy |
| Nov-03-17 | Reiterated | Maxim Group | Buy |
| Jun-06-17 | Initiated | Maxim Group | Buy |
| Aug-08-16 | Initiated | Northland Capital | Outperform |
View All
Sensus Healthcare Inc Stock (SRTS) Latest News
Market Fear: Is Sensus Healthcare Inc forming higher highs and higher lowsQuarterly Earnings Summary & Verified Short-Term Trading Plans - baoquankhu1.vn
Q2 2025 Sensus Healthcare Inc Earnings Call Transcript - GuruFocus
Signal Recap: What are the future prospects of Sensus Healthcare Inc2026 Momentum Check & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Sensus Healthcare, Inc. (5TX.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
Surprises Report: Is Sensus Healthcare Inc subject to activist investor interest2026 Market Overview & Community Verified Swing Trade Signals - baoquankhu1.vn
Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Update - MarketBeat
Sensus Healthcare, Inc. (SRTS) Stock Drops Despite Market Gains: Important Facts to Note - MSN
Sensus Healthcare sues SkinCure over unpaid equipment debt By Investing.com - Investing.com Australia
IPO Launch: Can Sensus Healthcare Inc sustain earnings growth2026 Support & Resistance & Entry Point Strategy Guides - baoquankhu1.vn
Sensus Healthcare, Inc. (NASDAQ:SRTS) Given Consensus Rating of "Moderate Buy" by Analysts - marketbeat.com
Sensus Healthcare sues SkinCure over unpaid equipment debt - Investing.com
Sensus Healthcare Files Lawsuit Against Skincure Oncology For Breach Of Contract - TradingView
Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract - Stock Titan
Buybacks Report: Is Sensus Healthcare Inc a top pick in the sectorEarnings Risk Summary & Real-Time Volume Triggers - baoquankhu1.vn
Investment Recap: Can Sensus Healthcare Inc benefit from deglobalization2026 Highlights & Entry and Exit Point Strategies - baoquankhu1.vn
Why The Sensus Healthcare (SRTS) Story Is Shifting As Targets Diverge On 2026 Expectations - Yahoo Finance
Institution Moves: What are the future prospects of Sensus Healthcare IncTrade Analysis Report & Accurate Buy Signal Notifications - baoquankhu1.vn
Sensus Healthcare (NASDAQ:SRTS) Now Covered by Analysts at Alliance Global Partners - MarketBeat
Aug Levels: Is Sensus Healthcare Inc forming higher highs and higher lowsJuly 2025 Macro Moves & Breakout Confirmation Alerts - baoquankhu1.vn
Sensus Healthcare Inc. (SRTS) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Sensus Healthcare 2025 10-K: Revenue $27.48M, EPS $(0.47) - TradingView
Sensus Healthcare (NASDAQ: SRTS) posts 2025 loss and outlines growth strategy - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Sensus Healthcare, Inc. (NASDAQ:SRTS) Given Average Rating of "Hold" by Analysts - MarketBeat
Merger Talk: Is Sensus Healthcare Inc stock risky to hold now2025 AllTime Highs & High Conviction Buy Zone Alerts - baoquankhu1.vn
Aug Fed Impact: What are the future prospects of Sensus Healthcare Inc2025 Technical Patterns & Smart Money Movement Tracker - baoquankhu1.vn
Valuation Update: What are the future prospects of Sensus Healthcare IncJuly 2025 Gainers & Community Verified Trade Signals - baoquankhu1.vn
Sensus Healthcare launches cloud software for radiotherapy systems By Investing.com - Investing.com Australia
Insider Buying: Eric Sachetta Acquires Additional Shares of Sens - GuruFocus
Sachetta Eric buys Sensus Healthcare (SRTS) shares worth $7,620 By Investing.com - Investing.com Nigeria
Sachetta Eric buys Sensus Healthcare (SRTS) shares worth $7,620 - Investing.com
Director Eric Sachetta buys Sensus Healthcare (SRTS) shares in open market - Stock Titan
Sensus Healthcare launches cloud software for radiotherapy systems - Investing.com
Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base - marketscreener.com
Is Sensus Healthcare Inc. stock affected by interest rate hikes2025 Key Highlights & Expert Approved Trade Ideas - mfd.ru
Block Trades: Is Telephone and Data Systems Inc stock influenced by commodity pricesEarnings Beat & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Sensus Healthcare launches financing service for SRT systems - Investing.com India
Why Sensus Healthcare Inc. stock is rated strong buyQuarterly Portfolio Summary & Technical Buy Zone Confirmation - mfd.ru
Sensus Healthcare launches financing service for SRT systems By Investing.com - Investing.com Nigeria
Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology - BioSpace
SRTS: Maxim Group Lowers Price Target, Maintains Buy Rating | SR - GuruFocus
Sensus Healthcare, Inc. (NASDAQ:SRTS) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
Sensus Healthcare, Inc. (NASDAQ:SRTS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Finance
Can Sensus Healthcare Inc. stock sustain institutional interest2025 Key Lessons & Real-Time Stock Price Movement Reports - mfd.ru
SRTS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Wall Street Zen Downgrades Sensus Healthcare (NASDAQ:SRTS) to Sell - Defense World
SRTS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Sensus Healthcare Bets on 2026 Reimbursement Rebound - TipRanks
Sensus Healthcare Inc Stock (SRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sensus Healthcare Inc Stock (SRTS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sachetta Eric | Director |
Nov 21 '25 |
Buy |
3.93 |
7,000 |
27,510 |
140,113 |
| Sachetta Eric | Director |
Nov 13 '25 |
Buy |
4.50 |
2,500 |
11,250 |
133,113 |
| Sardano Joseph C | CHIEF EXECUTIVE OFFICER |
Nov 18 '25 |
Buy |
4.03 |
25,000 |
100,750 |
1,200,293 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 18 '25 |
Buy |
3.80 |
1,000 |
3,800 |
118,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 11 '25 |
Buy |
4.26 |
1,000 |
4,260 |
117,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Aug 13 '25 |
Buy |
3.37 |
1,000 |
3,370 |
116,839 |
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):